05/01/2020: Lab Advisory: CMS Issues Additional Guidance on SARS-CoV-2 Laboratory Testing

CDC's Laboratory Outreach Communication System (LOCS)

Audience: Clinical Laboratory Professionals

Level: Laboratory Advisory

CMS Issues Additional Guidance on SARS-CoV-2 Laboratory Testing

On April 30, 2020, the Centers for Medicare & Medicaid Services (CMS) released additional guidanceexternal icon to clarify:

  • The types of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests that are available, and whether or not they have received emergency use authorization by FDA
  • The Clinical Laboratory Improvement Amendments (CLIA) certifications under which each test can be performed
  • An explanation of requirements under each testing scenario
  • Information for Medicare beneficiaries on testing services and coverage

Online Resources:

Laboratory Outreach Communication System | Division of Laboratory Systems (DLS)

Center for Surveillance, Epidemiology, and Laboratory Services (CSELS)

Centers for Disease Control and Prevention (CDC)

LOCS@cdc.gov

www.cdc.gov/csels/dls/locs

Page last reviewed: May 1, 2020